IRIS Accounts Production v25.2.0.378 10961062 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh109610622023-09-30109610622024-09-30109610622023-10-012024-09-30109610622022-09-30109610622022-10-012023-09-30109610622023-09-3010961062ns15:EnglandWales2023-10-012024-09-3010961062ns14:PoundSterling2023-10-012024-09-3010961062ns10:Director12023-10-012024-09-3010961062ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010961062ns10:SmallEntities2023-10-012024-09-3010961062ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3010961062ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3010961062ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3010961062ns10:FullAccounts2023-10-012024-09-3010961062ns10:OrdinaryShareClass12023-10-012024-09-3010961062ns10:Director22023-10-012024-09-3010961062ns10:Director32023-10-012024-09-3010961062ns10:CompanySecretary12023-10-012024-09-3010961062ns10:CompanySecretary22023-10-012024-09-3010961062ns10:RegisteredOffice2023-10-012024-09-3010961062ns5:CurrentFinancialInstruments2024-09-3010961062ns5:CurrentFinancialInstruments2023-09-3010961062ns5:Non-currentFinancialInstruments2024-09-3010961062ns5:Non-currentFinancialInstruments2023-09-3010961062ns5:ShareCapital2024-09-3010961062ns5:ShareCapital2023-09-3010961062ns5:RetainedEarningsAccumulatedLosses2024-09-3010961062ns5:RetainedEarningsAccumulatedLosses2023-09-3010961062ns5:LandBuildings2023-09-3010961062ns5:PlantMachinery2023-09-3010961062ns5:FurnitureFittings2023-09-3010961062ns5:ComputerEquipment2023-09-3010961062ns5:LandBuildings2023-10-012024-09-3010961062ns5:PlantMachinery2023-10-012024-09-3010961062ns5:FurnitureFittings2023-10-012024-09-3010961062ns5:ComputerEquipment2023-10-012024-09-3010961062ns5:LandBuildings2024-09-3010961062ns5:PlantMachinery2024-09-3010961062ns5:FurnitureFittings2024-09-3010961062ns5:ComputerEquipment2024-09-3010961062ns5:LandBuildings2023-09-3010961062ns5:PlantMachinery2023-09-3010961062ns5:FurnitureFittings2023-09-3010961062ns5:ComputerEquipment2023-09-3010961062ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3010961062ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3010961062ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-09-3010961062ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-09-3010961062ns10:OrdinaryShareClass12024-09-30
REGISTERED NUMBER: 10961062 (England and Wales)










Unaudited Financial Statements

for the Year Ended 30 September 2024

for

Rose Petals Health Care Ltd

Rose Petals Health Care Ltd (Registered number: 10961062)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Rose Petals Health Care Ltd

Company Information
for the Year Ended 30 September 2024







DIRECTORS: Shiny Clare Mathews
Shinu Clare Mathews
Sharon Sajeev





SECRETARIES: Sharon Sajeev
Sandra Sanu
Shon Sajeev





REGISTERED OFFICE: 376-378 Rochdale Road
Middleton
Manchester
M24 2QQ





REGISTERED NUMBER: 10961062 (England and Wales)





ACCOUNTANTS: SKS Justa & Co Ltd
Justa House
206-208 Holbrook Lane
Coventry
CV6 4DD

Rose Petals Health Care Ltd (Registered number: 10961062)

Balance Sheet
30 September 2024

2024 2023
Notes £    £   
Fixed assets
Tangible assets 4 193,045 189,582

Current assets
Debtors 5 1,089,993 606,694
Cash at bank and in hand 52,624 12,725
1,142,617 619,419
Creditors
Amounts falling due within one year 6 (1,325,300 ) (382,620 )
Net current (liabilities)/assets (182,683 ) 236,799
Total assets less current liabilities 10,362 426,381

Creditors
Amounts falling due after more than one year 7 (29,333 ) (139,550 )
Net (liabilities)/assets (18,971 ) 286,831

Capital and reserves
Called up share capital 8 3 3
Retained earnings (18,974 ) 286,828
Shareholders' funds (18,971 ) 286,831

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Rose Petals Health Care Ltd (Registered number: 10961062)

Balance Sheet - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 September 2025 and were signed on its behalf by:





Sharon Sajeev - Director


Rose Petals Health Care Ltd (Registered number: 10961062)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Rose Petals Health Care Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of consideration received or receivable excluding discounts, rebates for the services provided in the normal course of business. Expenses include VAT wherever applicable as company cannot reclaim it.

TANGIBLE FIXED ASSETS
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less residual values over the useful life on the following basis:

Fixtures and fittings 25% WDV
Computer Equipment 25% WDV
Plant & Machinery 10% WDV
Land & Building 10% SLM

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

CASH AND CASH EQUIVALENTS
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Rose Petals Health Care Ltd (Registered number: 10961062)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements ,when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

BASIC FINANCIAL ASSETS
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

CLASSIFICATION OF FINANCIAL LIABILITIES
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

BASIC FINANCIAL LIABILITIES
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

EQUITY INSTRUMENTS
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

EMPLOYEE BENEFIT
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 60 (2023 - 52 ) .

Rose Petals Health Care Ltd (Registered number: 10961062)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 October 2023 150,507 8,041 116,275 11,415 286,238
Additions - 18,504 5,780 12,521 36,805
At 30 September 2024 150,507 26,545 122,055 23,936 323,043
DEPRECIATION
At 1 October 2023 23,551 1,566 64,568 6,971 96,656
Charge for year 15,051 1,243 13,122 3,926 33,342
At 30 September 2024 38,602 2,809 77,690 10,897 129,998
NET BOOK VALUE
At 30 September 2024 111,905 23,736 44,365 13,039 193,045
At 30 September 2023 126,956 6,475 51,707 4,444 189,582

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tiffin Box Ltd 49,600 -
Other debtors 1,015,950 606,694
Corporation tax- receivable 17,291 -
Prepayments 7,152 -
1,089,993 606,694

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,000 10,000
Corporation Tax Payable 17,747 63,792
Paye Control account 292,659 -
Pension Liability 12,826 2,969
Other creditors - 13,500
Rent deposit account 92,500 -
Wages control account 101,779 -
Guardian Health Care PVT Ltd 183,208 242,450
Rose Petals Management ltd 19,000 -
Directors' current accounts 595,521 49,849
Accruals 60 60
1,325,300 382,620

Rose Petals Health Care Ltd (Registered number: 10961062)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Short term loan (Iwoca loan) 17,670 117,887
Bounce Back Loan (long term) 11,663 21,663
29,333 139,550

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
3 Ordinary shares 1 3 3